Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce the appointment from 1 September 2017 of two new Directors with responsibilities for graduate studies matters across the Medical Sciences Division:

Director of the Medical Sciences Division Graduate School: Professor Robert Gilbert 

Professor Robert Gilbert will become Director of the Medical Sciences Graduate School (including the Medical Sciences Doctoral Training Centre) on 1 September 2017, succeeding Professor Anton van der Merwe. His appointment is for three years in the first instance, with responsibilities for strategic direction and leadership on graduate studies matters across all departments within the Medical Sciences Division, and advocating for the Medical Sciences Graduate School at all levels, both within the collegiate University and externally with funding bodies and other agencies. Professor Gilbert is professor of biophysics with research interests in protein science and structural biology. He is currently Director of Graduate Studies for the Nuffield Department of Clinical Medicine (NDM) and Vice-Chair of the Divisional Graduate School Committee. He is also Managing Editor of European Biophysics Journal.

Director of the Oxford-MRC Doctoral Training Partnership: Professor Marella de Bruijn

Marella de BruijnProfessor Marella de Bruijn will become Director of the Oxford – Medical Research Council Doctoral Training Partnership (MRC DTP) on 1 September 2017. This is a new role following a re-organisation of leadership responsibilities, also for three years in the first instance, with responsibilities for leading the delivery of the MRC DTP and leading on the University’s preparation of future bids for MRC DTP funding. Professor de Bruijn is associate professor of developmental haematopoiesis with research interests in developmental and stem cell biology. She is currently Director of Graduate Studies for the Radcliffe Department of Medicine (RDM), Chair of the Oxford-MRC DTP Steering Committee, Chair of the MRC Weatherall Institute of Molecular Medicine’s (WIMM) Graduate Studies Committee, and a programme leader in the MRC Molecular Haematology Unit in the WIMM.

 

We should also like to take this opportunity to offer the Division’s heartfelt thanks to Professor Anton Van Der Merwe, as he steps down from the Directorship of the Graduate School, for his outstanding contribution to graduate studies in the Medical Sciences, and his superb leadership since the School’s inception in 2010.  Without his vision and dedication, the Graduate School would not have been successfully established. 

Similar stories

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards and Appointments General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.